Latest / Decera Clinical Education Oncology Podcast
Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms
In this episode, Amy E. DeZern, MD, MHS, and Srdan Verstovsek, MD, provide medical oncology and hematology perspectives on new data from ASH 2020 in MDS and MPNs, with topics including:
3-year OS results with RIC allogeneic transplantation in patients with higher-risk MDS in the BMT CTN 1102 study
A post hoc analysis of phase II data on the addition of pevonedistat to azacitidine in higher-risk MDS patients
5-year results of ropeginterferon α-2b in polycythemia vera from the CONTINUATION-PV study
Phase II results of luspatercept for anemia in patients with myelofibrosis who are transfusion…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.